Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician

Not Applicable

Active, not recruiting

• Conditions: Chronic Heart Failure
• Interventions: Other: Incentive letter for pneumococcal vaccination to the patient and to the GP

• Registration Number: NCT06360315
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-02
• Status Verified: 2024-04
• Primary Completion: 2024-04
• Study First Submitted: 2024-04-08
• Study First Submitted QC: 2024-04-08
• Last Update Submitted: 2024-04-08
• Study First Posted: 2024-04-11
• Last Update Posted: 2024-04-11
• Study Completion: 2024-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 12000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Incentive letter for pneumococcal vaccination to the patient and to the GP	Incentive letter for pneumococcal vaccination to the patient and to the GP	-

Primary Outcome Measures

Name	Time	Method
1-year Pneumococcus vaccination rate	at 1-year

Secondary Outcome Measures

Name	Time	Method
1-year all-cause mortality rate	at 1-year
1-year specific hospital admission rate	at 1-year
1-year all-cause hospital admission rate	at 1-year

Trial Locations

Locations (1)

Montpellier University Hospital; 🇫🇷 Montpellier, France